A mutation of the β3-adrenergic receptor is associated with visceral obesity but decreased serum triglyceride

Diabetologia

Volumn 40, Issue 4, 1997, Pages 469-472

  Kim Motoyama, H ^a   Yasuda, K ^b   Yamaguchi, T ^c   Yamada, N ^a   Katakura, T ^d   Shuldiner, Alan R ^e   Akanuma, Y ^b   Ohashi, Y ^c   Yazaki, Y ^a   Kadowaki, T ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b INSTITUTE FOR ADULT DISEASES   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d Nippon Express Hlth Ins Society   (Japan)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

3 adrenergic receptor; body mass index; lipolysis; triglyceride; visceral obesity

Indexed keywords

BETA 3 ADRENERGIC RECEPTOR; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; COMPUTER ASSISTED TOMOGRAPHY; DYSLIPIDEMIA; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HYPERTENSION; INSULIN RESISTANCE; LIPOLYSIS; MAJOR CLINICAL STUDY; MALE; MUTATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SYNDROME X; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; ALLELES; ARGININE; BODY MASS INDEX; CHOLESTEROL; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; DIABETES MELLITUS, TYPE 2; GENOTYPE; GLUCOSE INTOLERANCE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; INSULIN; MALE; MIDDLE AGED; OBESITY; PHENOTYPE; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, ADRENERGIC, BETA-3; REFERENCE VALUES; TRIGLYCERIDES; TRYPTOPHAN;

EID: 8044233066     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250050702     Document Type: Article

References (10)

1. Krief S, Lönnqvist F, Raimbault S et al. (1993) Tissue distribution of β3 adrenergic receptor mRNA in man. J Clin Invest 91: 344-349
2. Matsuzawa Y, Simomura I, Nakamura T et al. (1995) Pathophysiology and pathogenesis of visceral fat obesity. Obes Res [Suppl 2]: 187-194
3. Zamboni M, Armellini F, Cominacini L et al. (1994) Obesity and regional body fat distribution in men: separate and joint relationships to glucose tolerance and plasma lipoproteins. Am J Clin Nutr 60: 682-687
4. Walston J, Silver K, Bogardus C et al. (1995) Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the β3 adrenergic receptor gene. New Engl J Med 333: 343-347
5. Widén E, Lehto M, Kanninen T et al. (1995) Association of a polymorphism in the β3 adrenergic receptor gene with features of the insulin resistance syndrome in Finns. New Engl J Med 333: 348-351
6. Clément K, Vaisse C, Manning BSJ et al. (1995) Genetic variation in the β3 adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. New Engl J Med 333: 352-354
7. Kadowaki H, Yasuda K, Iwamoto K et al. (1995) A mutation in the β3 adrenergic receptor gene is associated with obesity and hyperinsulinemia in Japanese subjects. Biochem Biophys Res Commun 215: 555-560
8. Diabetes mellitus (1985) Report of a WHO study group, World Health Organ Techn Rep Series 727: 7-113
9. Lönnqvist F, Thörne A, Nilsell K et al. (1995) A pathogenic role of visceral fat β3-adrenoceptors in obesity. J Clin Invest 95: 1109-1116
10. Li LS, Lönnqvist F, Luthman H et al. (1996) Pathogenic characterization of the Trp64Arg polymorphism in the β3-adrenergic receptor gene in normal weight and obese subjects. Diabetologia 39: 857-860